Eswaran et al. 16 performed transcriptome analysis of 17 breast cancers, and noted significant differences in splicing signatures in TNBC, non-TNBC and HER2+ breast cancers when compared to NBS (non tumorigenic). The gene discussed is ERBB2; the disease is breast cancer.